ABEV - Ambev S.A.
| Previous Close | 4.7900 |
| Open | 4.7700 |
| Bid | 4.6600 x 47300 |
| Ask | 4.6500 x 40000 |
| Day's Range | 4.6500 - 4.8100 |
| 52 Week Range | 3.7700 - 5.4500 |
| Volume | 23,889,020 |
| Avg. Volume | 25,810,265 |
| Market Cap | 72.825B |
| Beta (3Y Monthly) | 0.89 |
| PE Ratio (TTM) | 26.48 |
| EPS (TTM) | 0.1760 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.24 (5.00%) |
| Ex-Dividend Date | 2018-12-19 |
| 1y Target Est | 5.52 |
- InvestorPlace
Ambev Stock Might Be the Best Beer Bet Heading into 2020
Back in April, I featured Brazilian beer company Ambev (NYSE:ABEV) in an article about the best large-cap stocks to own under $10. As I write this, Ambev stock is up 4.5%.Source: Daniel Spiess via FlickrThe two other stocks recommended: Ford (NYSE:F) is down 1.6% and Sirius XM (NYSE:SIRI) is up 13.7%. Over the same five months, the S&P 500 is up 2.5%, an indication that low-priced stocks did well over the summer.As for Anheuser-Busch (NYSE:BUD), who owns more than 60% of ABEV stock is up 6.9% over the same period, 240 basis points higher than its Brazilian subsidiary. However, year to date it's up 45.0% including dividends through Sept. 11, 2.4 times Ambev's total return for the year. InvestorPlace - Stock Market News, Stock Advice & Trading TipsWith three-and-a-half months left in 2019, I'm wondering if ABEV, BUD, or some other beer stock is the best bet heading into 2020. Ambev Stock is the Best BetAmbev's 15-year total annual return is quite good, at 11.2%. That trails both its brewing peers and the Brazilian market at 13.5%. However, the entire U.S. market over this period could only muster a total return of 9.3%. * 10 Battered Tech Stocks to Buy Now My InvestorPlace colleague Vince Martin recently highlighted in an article in late August that Ambev has a much stronger balance sheet than its parent and is growing its normalized EBITDA on an organic basis at more than 10% per year. In the first six months of 2019, Ambev's revenues increased by 7.4%. Three of its operating segments: Brazil, Central America and the Caribbean, and Canada delivered growth while only the company's South American division (excluding Brazil) experienced declining sales. South America might be experiencing a craft beer boom but Ambev's holding its own in a very competitive market. It's also important to remember that Ambev also makes non-alcoholic beverage products. In the first six months of 2019, it grew this segment by 19.6%, accounting for 15% of Ambev's overall revenues. Although Ambev has only paid an eight-cent dividend so far in 2019, its goal is to deliver an average annual yield of 5%. Currently, its forward dividend yield is 5.2%. Over the long haul, buying ABEV stock under $5 should deliver above-average results, including the dividends. Bud's the CallEven though Budweiser might have a ton of debt on its balance sheet (its net debt at the end of June was $104.2 billion) it still managed to generate $9.1 billion in free cash flow in the first six months of the year. On an annualized basis over the trailing 12 months, BUD had $11.5 billion in free cash flow, $54.1 billion in revenue, and a free cash flow margin of 21.1%. This means it's generating 21 cents of free cash flow for every $1 of revenue.Anheuser-Busch said to be reviving its IPO plans for its Asian business, a move that's expected to raise $5 billion and give it additional liquidity on the remainder of its ownership stake, the company's giving itself financial flexibility to pay down debt, repurchase shares, buy a cannabis company, or countless other things it could do with the funds. The point is, Anheuser-Busch is the largest beer company in the world. Investors shouldn't have a problem with a dividend yield of 3.5% given the appreciation it's experienced so far in 2019. The Bottom Line on Ambev StockIf you're not sure which beer company to back, a good alternative would be to buy a thematic portfolio, either through an ETF, mutual fund, or third-party provider such as Motif Investing. Motif currently has a portfolio called "Take a Shot" that invests in makers of alcoholic beverages including BUD and ABEV, which account for 19.4% and 16.6% of the portfolio, respectively. Beer stocks account for 46.3% of the portfolio with wine and spirits, accounting for the rest.Over the past year, it's generated a return of 8.6%, better than both the S&P 500 and the Invesco Dynamic Food & Beverage ETF (NYSEARCA:PBJ). At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Battered Tech Stocks to Buy Now * 7 Strong-Buy Stocks Hedge Funds Are Buying Now * The 7 Best Penny Stocks to Buy The post Ambev Stock Might Be the Best Beer Bet Heading into 2020Â appeared first on InvestorPlace.
- InvestorPlace
On the Dip, Ambev Stock Looks Attractive but Risky
It would appear there's a strong "buy the dip" case for Ambev (NYSE:ABEV) stock at the moment. Ambev stock has pulled back some 20% in barely a month on almost no news.Source: Daniel Spiess via FlickrReports in Brazilian media this month cited testimony that alleged the company was involved in the country's long-running corruption scandal, often referred to as Operation Car Wash. Ambev has denied any involvement. The company also pointed out that beverage taxes spiked in 2015 -- an increase the bribes ostensibly were meant to prevent. * 7 Tech Industry Dividend Stocks for Growth and Income Meanwhile, Ambev actually posted a blowout second quarter report last month, with Ambev stock touching a 52-week high on the news. A month later, the stock seems on track to touch a 2019 low. With a reported dividend yield of 5.5%, a more reasonable valuation, and potential growth in Latin America and Canada, the decline seems to present an opportunity.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThat may be the case. ABEV is cheaper. Growth has been more impressive than it appears. But there are risks here, too -- risks highlighted by the recent decline. Investors should take a look at buying the dip in ABEV stock. They should also understand that the declines can continue. The Case for Ambev StockThere's a lot to like when it comes to Ambev stock. Valuation isn't necessarily cheap: the stock trades at 23.6x trailing twelve-month adjusted EPS. But EV/EBITDA, below 13x, is more attractive.In the context of the industry, those multiples are relatively benign. Anheuser-Busch InBev (NYSE:BUD), who owns over 60% of Ambev, trades at about 12x EV/EBITDA with a much weaker balance sheet. (A-B had to cut its dividend to manage its debt. Ambev has net cash.) Boston Beer (NYSE:SAM) trades at a massive premium to ABEV stock. Constellation Brands (NYSE:STZ,NYSE:STZ.B) trades at 21x forward earnings despite weaker growth of late.Investors usually are willing to pay a premium for beer or spirits companies because growth can last for decades. For a company like Ambev, whose leading brands in Brazil include Skol, Brahma, and Antarctica, that can be the case.Meanwhile, recent performance looks solid. Earnings took a tumble in 2016, owing to the aforementioned tax hike in Brazil. But normalized EBITDA, as the company terms it, increased nearly 9% year-over-year on an organic basis in the first half despite a big jump in input costs. That follows a 14% increase in 2018 on the same basis.To top it off, ABEV stock provides a solid dividend. Like many overseas companies, Ambev doesn't give a consistent payout. (In fact, it hasn't yet declared a dividend for this year, which is unusual.) But the 2018 payout totaled 12.6 cents - suggesting a 2.9% yield.So there's a nice combination of growth, value, and income -- at a cheaper price to boot. The Risks to ABEV StockThat said, the risks here need to be monitored as well. It's tempting to argue that the 20% decline from post-earnings highs came on no news, bribery allegations aside. But that doesn't mean they came for no reason.Over half of the company's profit comes from Brazil. (About 10% comes from Canada, where the company sells Lablatt beer. The remainder comes from elsewhere in Latin America and the Caribbean.) And investors have quickly soured on Brazilian stocks. The iShares MSCI Brazil Capped ETF (NYSEARCA:EWZ) has declined 14% in the past month.A weaker Brazilian real is an issue. But there is real emerging market risk here as well, with Argentina another sore spot. And so the fact that ABEV stock is cheaper than U.S. beer producers may not mean the stock is cheap. It probably should trade at a discount, given macroeconomic uncertainty and higher volatility.The other issue is the overall health of beer. Certainly, U.S. trends don't look particularly positive. Even SAM stock - which has gained over 80% - has benefited from non-beer growth.At the moment, the overall beer market in Brazil, at least, appears to be growing. But craft brewers are making inroads. The former 'set it and forget it' nature of buying beer stocks might be over -- as witnessed by the huge plunge in BUD stock last year.Both risks have hit ABEV stock hard in recent years. The case for ABEV wasn't terribly different last year at $7, or above $6 back in 2014. Returns for most shareholders, dividends included, have been negative over the past five years. Maybe this time is different; maybe ABEV stock finally is too cheap. Investors have said that before.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Tech Industry Dividend Stocks for Growth and Income * 7 Stocks the Insiders Are Buying on Sale * 7 of the Worst Stocks on Wall Street The post On the Dip, Ambev Stock Looks Attractive but Risky appeared first on InvestorPlace.
- InvestorPlace
10 Stocks Under $5 to Buy for Fall
In most cases regarding equity investing, you want to stay with established names. Although cheap stocks to buy may tempt you psychologically - you get more shares for your buck - they're usually not reliable over the long haul. On the other hand, blue chips, with a patient enough timeline, have consistently returned solid gains.That said, on certain occasions and for risk-tolerant investors, cheap stocks do have a place in your portfolio. For instance, many lesser-capitalized companies fly under the radar. Thus, they might move in ways that don't necessarily correlate with broader benchmark indices. In a bull market, that spells trouble. However, in uncertain times like these, cheap stocks to buy may offer an unexpected hedge.Second, the most obvious appeal for cheap stocks are their price tags. If you look at your usual suspects in the S&P 500 or the Dow Jones, many of these equities have high paper values. And for some giants of industry like Amazon (NASDAQ:AMZN) or Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL), they feature four-figure prices. Psychologically, it's more challenging to justify spending so much money for one share of a company.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThird, and on a related point, cheap stocks to buy are available for virtually all investors with a living wage. Sure, you can buy the aforementioned alpha dogs through brokerages specializing in fractional equity ownership. However, you'd have to go through a middle man, which may not make sense for some investors. * 7 Safe Dividend Stocks for Investors to Buy Right Now Finally, I think cheap stocks are fun. Because they don't generate as much attention, they force you to do your own digging, which offers intrinsic value.And if you don't have any ideas of your own, here are my picks for cheap stocks to buy. Ambev (ABEV)Source: Daniel Spiess via FlickrStereotypically, most people associate cheap stocks to buy - especially those under $5 - with soon-to-be worthless companies. However, that's not always the case, as beverage specialist Ambev (NYSE:ABEV) demonstrates. A Brazilian brewing company under the Anheuser Busch Inbev (NYSE:BUD) umbrella, ABEV stock is a few cents shy of breaking above $5.At this price point, ABEV stock is what most analysts would consider a penny stock. Still, I really like the value proposition here for two reasons. First, beverage experts predict that the Latin American beer market in which Ambev plies its trade will grow to nearly $125 billion in 2025. Moreover, consumers in this region have developed a taste for premium beers, which suits ABEV stock well.Second, Latin American demographics favor investments like ABEV stock. That's because this region features the greatest proportion of young people anywhere in the world. It is true that many economic challenges exist there, however, we're talking about beer, which isn't exactly a massive outlay of cash. Genworth Financial (GNW)Genworth Financial (NYSE:GNW) is a very interesting name among cheap stocks to buy for several reasons. As a former subsidiary of industrial conglomerate General Electric (NYSE:GE), GNW stock has some storied history. More importantly, Genworth is principally a mortgage insurer. With relative stability in the domestic economy, GNW seems like a solid bet for a penny stock.But these are really side issues for the true reason to speculate on GNW stock. Almost three years ago, China Oceanwide Holdings announced their intent to buy out Genworth. But since then, the proposed deal has been extended multiple times pending regulatory approval.In a bid to accelerate the process, Genworth recently divested its Canadian unit for 2.4 billion CAD. That skyrocketed the GNW stock price as the markets saw the move as a strong positive. * 15 Growth Stocks to Buy for the Long Haul That said, the deteriorating relationship between the U.S. and China is a problem. Thus, if you're going to gamble, gamble moderately. Kinross Gold (KGC)Source: Shutterstock As I alluded to earlier, cheap stocks to buy are usually that way for a reason. And while they're superficially attractive, their fundamental problems tend to outweigh the positives over the long run. However, I'm reasonably confident that Kinross Gold (NYSE:KGC) and KGC stock can prove to be that rare case where a cheap equity has a favorable risk-reward profile.The best part about KGC stock is that I don't really need to spend too much time arguing the bull case: geopolitical underpinnings do enough of that. As you're all aware, the U.S.-China trade war recently took a turn for the worst. And probably in preparation for this diplomatic downgrade, the Federal Reserve cut benchmark interest rates.Therefore, we have a situation where more money is chasing after fewer goods. That's very positive for gold and silver bullion, which have been disappointing investments for years. Further, I believe the industry tailwinds are strong enough to overcome the individual challenges impacting KGC stock. Lloyds Banking Group (LYG)Source: Shutterstock If we're headed toward a correction in the markets, I'm not sure if I want to hold finance-related investments. That's especially the case regarding cheap stocks in the financial industry. Nevertheless, I believe speculators should take a long look at Lloyds Banking Group (NYSE:LYG). Even in times of turmoil and confusion, I think LYG stock has favorable tailwinds.First, let's talk about the obvious: LYG stock is one of the U.K.'s most storied investments. You think you own shares of an old company? Lloyds' heritage goes back over 250 years. To put that into perspective, the U.S. wasn't a thing back then. And although heritage is no guarantor of long-term viability, I don't think the British would let Lloyds crumble. * 7 Stocks Under $7 to Invest in Now Second, LYG stock is incredibly undervalued. Levering an enterprise value of $113 billion, its current price-earnings ratio is less than 10-times trailing earnings. Sure, business has not gone well for the U.K. over the years. However, the selloff seems a bit overbaked. Hexo (HEXO)Source: Shutterstock One of my favorite marijuana-based cheap stocks to buy, Hexo (NYSE:HEXO) has incurred severe choppiness this year. And in my best attempt to catch a falling knife, I bought shares around mid-July. That did not serve me well, as Hexo stock veritably plunged, at one point dipping below $4.Admittedly, holding Hexo stock has been a painful experience. But I genuinely believe that the legal marijuana sector will spark a radical paradigm shift in the markets. During this time, the extraordinary bullishness should lift all boats, including smaller outfits like Hexo.And who knows? We might be witnessing this radical transformation as you read this. Currently, Hexo stock stands just a few pennies shy of $5. I don't think it will take much to move the needle north. * 8 Dividend Aristocrat Stocks to Buy Now No Matter What Hexo has an attractive partnership with Molson Coors Brewing (NYSE:TAP) to develop cannabis-infused drinks. This potentially gives the company an important foothold in the American cannabis market, where attitudes are shifting positively toward legalization. Sibanye Gold (SBGL)At time of writing, Sibanye Gold (NYSE:SBGL) is just a penny over $5. Technically, that disqualifies it from this list of cheap stocks to buy. However, I think most readers will agree with me that it's close enough to warrant consideration. Furthermore, SBGL stock fundamentally offers something that many other mining investments do not.First, let's talk about why SBGL stock took a severe tumble. Sibanye operates mining projects in multiple parts of the world, including the volatile South African market. And unfortunately for stakeholders, a labor dispute involving the underlying company's Lonmin mine caused the volatility. While labor unions demand higher wages, Sibanye claims that doing so would make the project economically unsustainable.Given how ugly these disputes can get, I can understand why people would avoid SBGL stock. However, because the precious metals market is rising sharply, there's a chance that both sides can reach an agreement later.Finally, Sibanye is one of the largest producers of palladium. This is one of the rarest metals on earth, and its spot price reflects it. Atlantic Power (AT)Source: Shutterstock In most cases, buying utility companies like Atlantic Power (NYSE:AT) make sense for their stable passive income. After all, nothing drives people crazier in this digitalized economy than not having power. Thus, utility firms represent reliable investments. However, AT stock doesn't quite fit the mold of this industry.For one thing, there's the fact that Atlantic Power doesn't pay out a dividend. Thus, this is a purely capital gains-based play. While that might startle some investors, keep in mind that the AT stock price is only $2.40. Therefore, we have some room for growth.Additionally, Atlantic Power has a very stable business. As an independent power producer, the company owns power generation assets in 10 states and two Canadian provinces. Furthermore, it usually does business with only large, creditworthy customers on extended contracts. * 10 Stocks to Buy on the Trade War Dip Finally, AT stock is currently at a low point. Earlier this year, shares briefly exceeded the $3 level. Thus, speculators have a chance to grab a quick profit. Blueknight Energy Partners (BKEP)Source: Shutterstock Due to the recent and rational decline in oil prices, investors may initially want to avoid Blueknight Energy Partners (NASDAQ:BKEP). Plus, the fact that it's one of the cheapest of cheap stocks to buy doesn't do it any favors. However, not all energy companies are built the same. Because of the variables involved, you may want to give BKEP stock a second chance.Primarily, I say this because Blueknight's main business is in midstream operations. Specifically, the company provides storage and processing services for crude oil products. This distinction separates BKEP stock from upstream and integrated energy companies in that Blueknight is less susceptible to price volatility. No matter what happens in the energy market, people still require energy to move around. Thus, midstream companies act as a critical pivot point toward the end delivery to the consumer.Plus, BKEP stock has been rising steadily since the first half of this April. With a share price of a little over a buck, Blueknight is certainly a tempting opportunity. XCel Brands (XELB)Source: Shutterstock Although I'm no expert, fashion is a brutal industry. Consumer trends can change on a dime. Therefore, a supply chain risk exists in that a product may arrive to the retail floor too late. But XCel Brands (NASDAQ:XELB) would like to change investors' perception of this sector.First, what does XCel do? I must say that the company does a terrible job of explaining its own business. Fortunately, we have CNBC contributor Krystina Gustafson, who describes the organization as a fast-fashion retailer like Zara or H&M, but geared toward upscale apparel and products.More critically for XELB stock, XCel hopes to disrupt the fashion industry by cutting the time involved from getting concept products into retail stores. Typically, a fashion company will take several months from blueprinting to distribution. XCel has dropped this process down to six weeks. * 7 Stocks the Insiders Are Buying on Sale You might think that's a game-changer for the industry, and it just might be. However, the risk (and the opportunity) is that the markets don't see it that way. Currently, XELB stock is trading hands for less than $2. BioDelivery Sciences International (BDSI)Source: Shutterstock I believe that BioDelivery Sciences International (NASDAQ:BDSI) stock has a lot of potential if you're willing to give it some patience. Also, it would help that you ignore the implications behind its sub-$5 price tag.Let's focus on the good news. BioDelivery Sciences has two main drugs in its pipeline: Belbuca and Bunavil. The former focuses on addressing chronic pain, which represents a major medical problem in the U.S. The latter addresses opioid dependence, which has rapidly escalated into a nationwide crisis.I'll grant you that there's something not right about a pharmaceutical company providing a solution to a pharmaceutical-based problem. However, I'm just going to look at this from a purely investment point of view. Demand for these two products, and especially for Bunavil, supports the speculative case for BDSI stock.As of this writing, Josh Enomoto is long LYG stock, HEXO stock, gold, silver, and palladium. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Real Estate Investments to Ride Out the Current Storm * 7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk * 7 Safe Dividend Stocks for Investors to Buy Right Now The post 10 Stocks Under $5 to Buy for Fall appeared first on InvestorPlace.
- Reuters
UPDATE 1-Brazil's Ambev calls bribery allegations 'false and incoherent'
Brazilian newspaper Estado de S. Paulo earlier reported that Antonio Palocci, a jailed former finance minister, had said in plea bargain testimony that the company made the payments to former presidents Luiz Inácio Lula da Silva and Dilma Rousseff. Palocci said he also received payments from the firm, according to the newspaper, which said it was the first time that Ambev, the Latin American and Canadian subsidiary of Anheuser Busch Inbev NV, has been caught up in the multi-year corruption probe known as Operation Car Wash.
- Reuters
Ex-Brazil finance minister says Ambev bribed two former presidents -report
A jailed former finance minister in Brazil has said in plea bargain testimony that beverage giant Ambev SA made "inappropriate payments" to former presidents Luiz Inácio Lula da Silva and Dilma Rousseff, according to a newspaper report. Brazilian newspaper Estado de S. Paulo, citing confidential court documents, said former Finance Minister Antonio Palocci told federal police he also personally received payments from the company that he said were aimed at preventing an increase in beverage taxes.
- Zacks
Ambev (ABEV) Looks Good: Stock Adds 9.1% in Session
Ambev (ABEV) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
- Motley Fool
Why AstraZeneca, Ambev, and Nokia Jumped Today
Solid earnings lifted some stocks despite a big market downturn.
- Reuters
UPDATE 2-Brazil brewer Ambev beats Q2 profit forecasts; shares up 9%
Brazilian beverages firm Ambev SA on Thursday posted a better-than-expected 8.5% rise in second-quarter net profit, triggering strong gains in its shares. The Latin American unit of Anheuser Busch InBev said net income reached 2.616 billion reais ($693.42 million), beating a consensus estimate of 2.286 billion reais ($606.58 million) compiled by Refinitiv. "2019 has been a good year for us and our portfolio is delivering healthy top line growth that is likely to continue going forward," Chief Executive Officer Bernardo Winik told analysts in a conference call.
- Insider Monkey
Here’s What Hedge Funds Think About Ambev SA (ABEV)
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]
- Zacks
Ambev Enters Oversold Territory
Ambev has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
- Zacks
3 Reasons Why You Must Hold on to AB InBev (BUD) Stock for Now
AB InBev (BUD) is a favored stock due to strong sales trends, strength in global brands and robust outlook. However, soft earnings trend due to currency headwinds and cost inflation cannot be ignored.
- Investopedia
The Top 5 Beer Stocks of 2018
The top beer stocks have a market cap exceeding $2 billion and are trading on leading American stock exchanges. Here are the top beer stocks of 2018.
- Zacks
Boston Beer Fortifies Craft Footprint with Dogfish Head Merger
Boston Beer (SAM) enters into a merger agreement with Dogfish Head Brewery in a cash and stock deal worth about $300 million.
- Zacks
The Zacks Analyst Blog Highlights: Unilever, General Mills, Sysco, Kimberly-Clark and Ambev
The Zacks Analyst Blog Highlights: Unilever, General Mills, Sysco, Kimberly-Clark and Ambev
- Zacks
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Scotts Miracle-Gro, Ambev, International Game Technology and Ubisoft Entertainment
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Scotts Miracle-Gro, Ambev, International Game Technology and Ubisoft Entertainment
- Zacks
5 Consumer Staples Stocks to Survive a Prolonged Trade War
With the trade war likely to intensify, consumer staples stocks are a prudent choice for investors.
- Zacks
5 Best Stocks to Buy for Sinful Gains This May
Sin stocks provide a stable stream of consumers, irrespective of market conditions, which leads to higher margins and solid profits.
- Reuters
Brazil's Ambev in stronger position to benefit from economic recovery -CEO
Brazilian beverages firm Ambev SA has emerged from the country's economic recession in a stronger position to compete in the beer market and is increasingly betting on premium brands to drive volumes up, executives said on Tuesday. "Despite some macro volatilities, we believe very confidently that we are in a stronger position to fully benefit from an economic recovery", Ambev's Chief Executive Officer, Bernardo Paiva, told analysts in a call to discuss quarterly results.
- Zacks
AB InBev (BUD) Q1 Earnings Miss, Sales Beat on Strong Volume
AB InBev (BUD) reports strong organic sales growth and top-line beat in first-quarter 2019 on strong volume growth, global premiumization and ongoing revenue-management initiatives.
- Reuters
Brazil's Ambev misses quarterly profit estimates amid higher costs
Brazilian beverage firm Ambev SA reported a 6.2 percent rise in first-quarter net profit on Tuesday which still missed market expectations amid a double-digit increase in the cost of goods sold and higher ...
- Reuters
Brazil's Ambev misses profit estimates in Q1
Brazilian beverages firm Ambev SA reported a 6.2 percent rise in first-quarter net profit but missed market expectations as a double-digit increase in cost of goods sold overshadowed growth in revenue ...
- Zacks
Molson Coors (TAP) Stock Falls on Q1 Earnings & Sales Miss
Molson Coors' (TAP) top and bottom lines miss estimates in first-quarter 2019, driven by soft volume, offset by higher pricing.
